CX Institutional’s BioMarin Pharmaceuticals BMRN Stock Holding History

CX Institutional’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Sell	234 -54	-19%	-$2.96K	﹤0.01%	1249
2026 Q1	$16K	Buy	288 +260	+929%	+$15.2K	﹤0.01%	1176
2025 Q4	$2K	Buy	+28	New	+$1.52K	﹤0.01%	1351
2021 Q4	–	Sell	-10	Closed	-$1K	–	399
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	930
2021 Q2	$1K	Buy	+10	New	+$793	﹤0.01%	929
2021 Q1	–	Sell	-17	Closed	-$1K	–	870
2020 Q4	$1K	Sell	17 -3	-15%	-$238	﹤0.01%	841
2020 Q3	$2K	Buy	+20	New	+$2.02K	﹤0.01%	800
2019 Q3	–	Sell	-27	Closed	-$2K	–	805
2019 Q2	$2K	Sell	27 -24	-47%	-$2.05K	﹤0.01%	743
2019 Q1	$5K	Buy	+51	New	+$4.73K	﹤0.01%	539

Other funds holding BMRN

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Inspirion Wealth Advisors Libertyville, Illinois $873M AUM 16.23% 1-Year Est. Return

Miller Global Investments Dallas, Texas $121M AUM